CONTACT
NAVARRA
+34 948 194 700
NAVARRA
×
INTRANET
PEOPLE FINDER
English
Español
WORK WITH US
INVESTOR AREA
/servlet/autocompletar/
Delete
¿QUIERE AYUDARNOS?
TRABAJE CON NOSOTROS
ÁREA DEL INVERSOR
About us
Universidad de Navarra Biomedical Campus
Research Center of the Clínica
Organization
Transparency Portal
Research
Research divisions
Research groups
Technological platforms
Research and clinical trials
Research Staff
Human Resources Strategy for Researchers (HRS4R)
Scientific activity
Innovation
Pipeline
Patents
Entrepreneurship | Spin off
Collaboration with companies
Investor Area
Training
Master's Degrees
Doctorate Programs
Training stays
Training contracts and grants
Collaborate with us
How to collaborate
Diseases
Collaboration projects
Collaborating companies
Transparency
News
News
Events
Home
>
News
>
News
Cima Universidad de Navarra news
Specialties
Choose by department
Adhesion and Metastasis
Adoptive Cell Therapy
Adoptive Cellular Therapy
Advanced Therapies for Pediatric Solid Tumors
Animal Models
Animal Production and Experimentation
Aptamer
Aptámeros y Química Médica
Atherothrombosis
Biobank
Biochemical Analysis and Cell Metabolism
Bioinformatics
Biomarkers and New Therapeutic Targets in Lung Cancer
Biomedical Engineering
Cancer Division
Cancer gene therapy
Cardiac Tissue Engineering
Cardiovascular Diseases
Combination Strategies for Translational Immunotherapy
Computational Biology
Congenital Encephalopathy Gene Therapy
Cytokine-Based Therapeutics
Cytometry
DNA and RNA Medicine
Dynamics of the antitumor immune response
Enable Technologies
Endoplasmic Reticulum Stress Response in Neurodegenerative Diseases
Epilepsy
Gene Therapy and Regulation of Gene Expression
Gene therapy for congenital hearing loss & AAV engineering
Gene Therapy in Neurological Disorders
Gene Therapy in Parkinson's Disease
Gene Therapy of Renal Diseases and Study of N-terminal Acetylation of Proteins
Genomics Unit
Heart Failure
Hemato-Oncology
Hepatic Diseases Gene Therapy
Hepatology
Hepatology: Carcinogenesis (HEPACAN)
Hepatology: Metabolism, epigenetics and liver cancer.
Image
Immunology and Immunotherapy
Immunomodulation and Tumor Microenvironment
Immunotherapy Strategies in Peritoneal Carcinomatosis
In vivo Organ Generation by Stem Cells
Lymphoproliferative Syndromes
Medicinal Chemistry
Micro-PET
Microphysiological Systems and Quantitative Biology
Molecular Therapeutics
Morphology
Neuroscience
Non-Coding RNA and Cancer Genome
Oncogenes and Effector Targets
Peptide
Porphyrias
Preclinical Models and Analysis Tools
Predictive Response Marker
Radioactive Facility
Regenerative Medicine
Regulación de la Expresión Génica
Renal Gene Therapy and Generation of Chimeric AAVs
RNA Biology and Therapy
Solid Tumor
Therapeutic Genes for Neurodegenerative Diseases
Therapeutic long non-coding RNAs and integrated stress in Cancer
Translational Hematology
Translational Oncology
Tumor Evasion and Novel Targets
Vaccine Development
Date from
Date to
Preclinical study improves treatment for most aggressive pediatric brain tumors
Researchers at Cima University of Navarra have found that the combination of two already known drugs paves the way for potential clinical trials to combat diffuse midline gliomas and high-grade gliomas in pediatric patients
April 24, 2024
Dr. Bruno Paiva receives an runner-up award at the 60th Anniversary Farmaindustria Young Researchers Awards
Dr. Bruno Paiva, director of the Myeloma Group of the Cima University of Navarra, was distinguished for his research focused on hematology and monoclonal gammopathies, with a special focus on multiple myeloma
April 22, 2024
The CRIS Foundation against cancer awards two researchers from the Cima University of Navarra
Sara Labiano and Virginia Laspidea have been distinguished in the categories of "Emerging Talent Leader" and "Out-back", respectively.
April 18, 2024
Dr. Ignacio Melero obtains one of the most prestigious grants from the European Research Council
He is one of the 4 Spanish researchers who has received an ERC Advanced Grant in the discipline of Life Sciences, endowed with 2.5 M euros
April 11, 2024
El Biobanco de la Universidad de Navarra conecta su plataforma de gestión de muestras con la herramienta REDCap
April 3, 2024
Blockade of a clotting protein during stroke process reduces brain damage in experimental models
Researchers at the Cima University of Navarra confirm for the first time that FXIII increases clot density and resistance to current treatments in thrombi of stroke patients
March 26, 2024
